EBAG9P1

Across TCGA pan-cancer cohorts, EBAG9P1 RNA is linked to patient survival in 20 of 34 cancer types, making it the most broadly survival-associated EBAG9P1 data layer.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher EBAG9P1 RNA is associated with better overall survival. In most high-consensus cancer types, elevated EBAG9P1 expression acts as an unfavorable survival marker, although some lineages such as HNSC and SKCM show a favorable association.

HNSC, SKCM, and UCS are the cancer types where EBAG9P1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
HNSC	OS	Tertile	IV	0.480	0.251	<.001	75	view →
SKCM	OS	Tertile	All	0.415	0.286	.002	38	view →
UCS	OS	Tertile	IV	0.883	0.296	.024	24	view →
LGG	OS	Quartile	All	0.646	0.412	<.001	24	view →
COAD	OS	Quartile	All	0.694	0.852	.004	24	view →
BRCA	DFS	Tertile	III,IV	0.934	0.772	.002	20	view →
CHOL	DFS	Median	II,III,IV	0.106	0.511	.011	18	view →
KICH	DFS	Median	II,III,IV	0.583	0.917	.007	14	view →
UVM	DFS	Quartile	III,IV	0.220	0.702	.023	12	view →
PRAD	OS	Median	All	0.977	1.000	.016	12	view →
THCA	OS	Tertile	II,III,IV	0.962	1.000	.023	11	view →
LUSC	OS	Quartile	All	0.839	0.724	.013	11	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 20 lineages.

EBAG9P1–HNSC (OS)

Open the HNSC breakdown →